Filing Details

Accession Number:
0001209191-11-042501
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-04 17:14:32
Reporting Period:
2011-08-02
Filing Date:
2011-08-04
Accepted Time:
2011-08-04 17:14:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398598 Hubert Birner C/O Horizon Pharma, Inc.
1033 Skokie Blvd., Suite 355
Northbrook IL 60062
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-02 113,361 $0.00 113,361 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 20,646 $0.00 134,277 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 27,371 $9.00 161,648 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 33,882 $9.00 195,530 No 4 P Indirect See FN
Common Stock Acquisiton 2011-08-02 409,116 $0.00 409,116 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 74,511 $0.00 483,627 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 98,784 $9.00 582,411 No 4 C Indirect See FN
Common Stock Acquisiton 2011-08-02 122,280 $9.00 704,691 No 4 P Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See FN
No 4 C Indirect See FN
No 4 C Indirect See FN
No 4 P Indirect See FN
No 4 C Indirect See FN
No 4 C Indirect See FN
No 4 C Indirect See FN
No 4 P Indirect See FN
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2011-08-02 401,927 $0.00 401,927 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-08-02 555,956 $0.00 555,956 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2011-08-02 44,364 $0.00 44,364 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2011-08-02 61,366 $0.00 61,366 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-08-02 0 $0.00 89,652 $9.00
Common Stock Convertible Promissory Notes Disposition 2011-08-02 0 $0.00 124,007 $9.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 210,120 Indirect See FN
Common Stock 757,347 Indirect See FN
Footnotes
  1. Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
  2. The securities are held of record by TVM Life Science Ventures VI, L.P. ("TVM VI"). The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
  3. Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
  4. The securities are held of record by TVM Life Science Ventures VI GmbH & Co. KG ("TVM VI GmbH"). The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein
  5. These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
  6. Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.